Multi-layer SPR biosensor for in-Situ Amplified monitoring of the SARS-CoV-2 omicron (B.1.1.529) variant

Tarik Bin Abdul Akib*, Md Masud Rana, Ibrahim M. Mehedi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

This article represents an analysis of the performance of multi-layer surface plasmon resonance (SPR) biosensors in detecting the transferable human SARS-CoV-2 Omicron (B.1.1.529) variant. The proposed multi-layer SPR biosensor performance is enhanced by integrating fine-tuning prisms, plasmonic metals, and two-dimensional (2D) transition metal dichalcogenides (TMDs) materials. To evaluate the performance of the multi-layer SPR sensor, the transfer matrix method (TMM) is employed. In numerical result, the proposed (CaF2/Cu/BP/Graphene) structure demonstrates the most favorable sensitivity and detection accuracy, characterized by a 410° angle shift sensitivity/refractive index unit (RIU). Additionally, the sensor achieves a detection accuracy (DA) of 0.4713, a quality factor (QF) of 94.25 RIU−1, a figure of merit (FOM) of 91.87, and a combined sensitivity factor (CSF) of 90.36. The presented sensor is also capable of detecting target biomolecule binding interactions between ligands and analytes at a range of concentrations (from 0 nM to 1000 nM), implying its potential use for detecting the omicron virus strain. The outcomes highlight the effectiveness of the presented sensor for real time, and label free detection, particularly in identifying the Omicron viral strain. Eventually, this research promises advanced biosensor technology, crucial for rapid viral variant detection and diagnostics.

Original languageEnglish
Article number100434
JournalBiosensors and Bioelectronics: X
Volume16
DOIs
Publication statusPublished - Feb 2024
Externally publishedYes

Keywords

  • Biosensor
  • COVID-19
  • Omicron (B.1.1.529)
  • SARS-CoV-2
  • SPR

Fingerprint

Dive into the research topics of 'Multi-layer SPR biosensor for in-Situ Amplified monitoring of the SARS-CoV-2 omicron (B.1.1.529) variant'. Together they form a unique fingerprint.

Cite this